Search research articles
Contact Us
Filters
Showing results (21-30 of 143) with videos related to
Page
of 15
Sort By:
Oncotarget
|
September 20, 2014
Selective methioninase-induced trap of cancer cells in S/G2 phase visualized by FUCCI imaging confers chemosensitivity
Shuya Yano, Shukuan Li, Qinghong Han, et al.
Cancer Diagnosis & Prognosis
|
July 4, 2024
Synergy of Rapamycin and Methioninase on Colorectal Cancer Cells Requires Simultaneous and Not Sequential Administration: Implications for mTOR Inhibition
Daniel Ardjmand, Motokazu Sato, Qinghong Han, et al.
Clinical Chemistry
|
August 28, 2004
3-Deazaadenosine, a stabilizer of whole-blood homocysteine content, does not interfere with the single-enzyme homocysteine assay while totally inhibiting the enzyme conversion homocysteine immunoassay
Qinghong Han, Xinghua Sun, Mingxu Xu, et al.
Anticancer Research
|
February 29, 2024
Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells
Daniel Ardjmand, Yutaro Kubota, Motokazu Sato, et al.
Cancer Diagnosis & Prognosis
|
November 6, 2023
Recombinant-methioninase-producing <i>Escherichia coli</i> Instilled in the Microbiome Inhibits Triple-negative Breast Cancer in an Orthotopic Cell-line Mouse Model
Yutaro Kubota, Qinghong Han, Sei Morinaga, et al.
Anticancer Research
|
June 27, 2025
The Triple Combination of Recombinant Methioninase, Rapamycin, and Chloroquine Synergistically Eradicates HCT116 Colon Cancer Cells
Jinsoo Kim, Qinghong Han, Byung Mo Kang, et al.
Anticancer Research
|
April 28, 2025
Combination of Recombinant Methioninase With Rapamycin or Chloroquine Is Synergistic to Highly Inhibit Triple-negative Breast Cancer Cells <i>In Vitro</i>
Jinsoo Kim, Qinghong Han, Byung Mo Kang, et al.
Anticancer Research
|
April 30, 2022
Stage IV Pancreatic Cancer Patient Treated With FOLFIRINOX Combined With Oral Methioninase: A Highly-Rare Case With Long-term Stable Disease
Yutaro Kubota, Qinghong Han, Chihiro Hozumi, et al.
Anticancer Research
|
July 27, 2022
Long-term Stable Disease in a Rectal-cancer Patient Treated by Methionine Restriction With Oral Recombinant Methioninase and a Low-methionine Diet
Yutaro Kubota, Qinghong Han, Kazuyuki Hamada, et al.
Cells
|
May 5, 2019
Efficacy of Recombinant Methioninase (rMETase) on Recalcitrant Cancer Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models: A Review
Kei Kawaguchi, Qinghong Han, Shukuan Li, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 143) with videos related to
Sort By:
Page
of 15
Oncotarget
|
September 20, 2014
Selective methioninase-induced trap of cancer cells in S/G2 phase visualized by FUCCI imaging confers chemosensitivity
Shuya Yano, Shukuan Li, Qinghong Han, et al.
Cancer Diagnosis & Prognosis
|
July 4, 2024
Synergy of Rapamycin and Methioninase on Colorectal Cancer Cells Requires Simultaneous and Not Sequential Administration: Implications for mTOR Inhibition
Daniel Ardjmand, Motokazu Sato, Qinghong Han, et al.
Clinical Chemistry
|
August 28, 2004
3-Deazaadenosine, a stabilizer of whole-blood homocysteine content, does not interfere with the single-enzyme homocysteine assay while totally inhibiting the enzyme conversion homocysteine immunoassay
Qinghong Han, Xinghua Sun, Mingxu Xu, et al.
Anticancer Research
|
February 29, 2024
Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells
Daniel Ardjmand, Yutaro Kubota, Motokazu Sato, et al.
Cancer Diagnosis & Prognosis
|
November 6, 2023
Recombinant-methioninase-producing <i>Escherichia coli</i> Instilled in the Microbiome Inhibits Triple-negative Breast Cancer in an Orthotopic Cell-line Mouse Model
Yutaro Kubota, Qinghong Han, Sei Morinaga, et al.
Anticancer Research
|
June 27, 2025
The Triple Combination of Recombinant Methioninase, Rapamycin, and Chloroquine Synergistically Eradicates HCT116 Colon Cancer Cells
Jinsoo Kim, Qinghong Han, Byung Mo Kang, et al.
Anticancer Research
|
April 28, 2025
Combination of Recombinant Methioninase With Rapamycin or Chloroquine Is Synergistic to Highly Inhibit Triple-negative Breast Cancer Cells <i>In Vitro</i>
Jinsoo Kim, Qinghong Han, Byung Mo Kang, et al.
Anticancer Research
|
April 30, 2022
Stage IV Pancreatic Cancer Patient Treated With FOLFIRINOX Combined With Oral Methioninase: A Highly-Rare Case With Long-term Stable Disease
Yutaro Kubota, Qinghong Han, Chihiro Hozumi, et al.
Anticancer Research
|
July 27, 2022
Long-term Stable Disease in a Rectal-cancer Patient Treated by Methionine Restriction With Oral Recombinant Methioninase and a Low-methionine Diet
Yutaro Kubota, Qinghong Han, Kazuyuki Hamada, et al.
Cells
|
May 5, 2019
Efficacy of Recombinant Methioninase (rMETase) on Recalcitrant Cancer Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models: A Review
Kei Kawaguchi, Qinghong Han, Shukuan Li, et al.
Page
of 15